Qingdao Haikun Pharmaceutical

Qingdao Haikun Pharmaceutical is a specialized pharmaceutical company based in Qingdao, China, focusing on the development of marine-derived medicines. The company is most recognized for its flagship product, Haikun Shenxi Capsule, which is a proprietary traditional Chinese medicine used for the treatment of chronic renal failure. By leveraging marine biological resources, the company addresses therapeutic needs in the field of nephrology. Their operations encompass research, development, and large-scale GMP-certified manufacturing of herbal and botanical drug products. Qingdao Haikun Pharmaceutical maintains a significant market share in the Chinese domestic market for chronic kidney disease treatments.